RAMUCIRUMAB, ERLOTINIB
I4T-MC-JVCY
Phase 3 small_molecule active
Quick answer
RAMUCIRUMAB, ERLOTINIB for Metastatic Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Metastatic Non-Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active